La Mobilière, TX Group, Ringier and General Atlantic form a joint venture to create a digital marketplace group. The CEO of the joint venture will be Gilles Despas, currently CEO of the Scout24 Switzerland
VectivBio Holding, clinical-stage biopharmaceutical company specialising in novel transformational treatments for severe rare conditions announced the acquisition of Comet Therapeutics, a biotechnology company that has been developing drugs to address previously untreatable inherited metabolic diseases.
HBM Healthcare Investments successfully issued CHF 100 million 1.125 per cent Bonds due 2027. The bonds will be admitted for trading and listing on the SIX Swiss Exchange. The advisors Homburger acted as counsel to HBM Healthcare
Vischer announced the addition of Karin Graf (pictured) to the firm’s litigation and arbitration team, in the role of partner. Graf assumes her new role as of September 1st. Graf brings with her more
Vischer’s dispute resolution team successfully represented a Swiss bank in a multi-faceted conflict, defending against allegations of corruption and breaches of contract as well as massive claims for damages. The dispute included commercial court
Dekra, the German vehicle inspection company, announced the acquisition of a minority stake in Spearhead, a Swiss company specializing in data analytics for automotive claims and vehicle lifecycle management. Homburger acted as legal counsel to
The Geneva International Motor Show (GIMS) announced its strategic partnership with Qatar Tourism at a press conference held on 25 August 2021 at the Doha Exhibition & Convention Center. The parties have joined forces to develop and
Astrocast, the leading Swiss IoT- focused nanosatellite company, floated its shares on the Euronext Growth market in Oslo. Prior to the listing on Euronext Growth Oslo, Astrocast offered new shares to investors and raised CHF 40
Alnylam Pharmaceuticals, the RNAi therapeutics company, has promoted Francesco Vazzana (pictured) into the role of senior director, legal counsel international. Vazzana, who is based in Zug, Switzerland, will be reporting to Arianna Greco, Alnylam’s
Biopharmaceutical company Relief Theraputics Holding, has a binding agreement with two institutional U.S. investors completed. The contract provides for the purchase of Relief shares with a total value of CHF 15 million, which come from
